Persistent Pain After Breast Cancer Treatment With Docetaxel
N/A
18 Years
80 Years
18 Years
80 Years
Not Enrolling
Female
Breast Neoplasms, Pain, Postoperative, Neuralgia, Lymphedema
Female
Breast Neoplasms, Pain, Postoperative, Neuralgia, Lymphedema
Trial Information
Persistent Pain After Breast Cancer Treatment With Docetaxel
Inclusion Criteria:
- Treated for primary breast cancer in Denmark 2007-2008
- Age between 18-80 years
- No recurrent cancer
- Female
Exclusion Criteria:
- Previous breast surgery same side (including plastic and reconstructive surgery)
- Bilateral breast surgery
- Recurrent cancer or metastatic cancer
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Cross-Sectional
Outcome Measure:
Docetaxel as a risk factor for development of persistent pain
Outcome Time Frame:
Between 2-3 years post surgery
Safety Issue:
No
Authority:
Denmark: The Danish National Committee on Biomedical Research Ethics
Study ID:
H-1-2010-028
NCT ID:
NCT01279018
Start Date:
October 2010
Completion Date:
January 2011
Related Keywords:
- Breast Neoplasms
- Pain, Postoperative
- Neuralgia
- Lymphedema
- Persistent postsurgical pain
- breast cancer
- postmastectomy pain syndrome
- neuropathic pain
- Breast Neoplasms
- Neoplasms
- Lymphedema
- Neuralgia
- Pain, Postoperative
Name | Location |
|---|
